Bayer Germany Reverse-Switches Phytohustil, Expands Iberogast

Bayer Vital is taking the unusual step to reverse-switch its Phytohustil range of herbal cough medicines in Germany, to strengthen the role of pharmacy in ensuring consumers access the right products for their needs. The company is also launching a new celandine-free addition to its embattled Iberograst brand of herbal gastrointestinal medicines. 

Pharmacy_Consultation
• Source: Shutterstock

Bayer Vital GmbH has made the unusual decision of reverse-switching its own products, in this case two out of three products in the Phytohustil range of herbal cough medicines it markets in Germany.

Currently available for self-selection outside pharmacy, Phytohustil Hustenreizstiller Sirup has been recommended by Germany’s Expert Advisory Committee for Pharmacy-Only Issues...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rx-to-OTC Switch

Haleon Study: Self-Care Policies Could Save Finland €60m Per Year

 
• By 

Creating a working group to drive Rx-to-OTC switch is one of the ways in which Finland could expand self-care and save €60m per year for the country's health system, suggests a recently published report commissioned by Haleon.

PAGB: UK Gov Must Invest In Self-Care To Realize ‘Untapped Potential’

 
• By 

Reacting to chancellor Rachel Reeves' 2025 public spending review, PAGB welcomed increased funding for healthcare and life sciences while stressing the need to promote self-care practices.

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By 

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

AESGP Annual Meeting: Commission Must ‘Think Carefully’ Before Reverse-Switching Antimicrobials

 
• By 

If the European Commission is serious about improving the competitiveness of the European Union, it should ditch the idea of making commonly used OTC antimicrobials like thrush treatments and cold sore creams prescription-only, warns Greek Medicines Agency president Evangelos Manolopoulos

More from Health